Valenza, Giuseppe <br/><br/>
First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany.  [electronic resource] 

 -  Journal of global antimicrobial resistance  06 2019 
 - 305-308 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2213-7173 
<br/><br/><label>Standard No.: </label>10.1016/j.jgar.2019.01.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--pharmacology<br/>Cefotaxime<br/>Ceftazidime<br/>Child<br/>Child, Preschool<br/>Ciprofloxacin<br/>Drug Resistance, Multiple, Bacterial--genetics<br/>Escherichia coli--genetics<br/>Escherichia coli Infections--epidemiology<br/>Escherichia coli Proteins--genetics<br/>Female<br/>Germany<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Microbial Sensitivity Tests<br/>Middle Aged<br/>Molecular Epidemiology<br/>Multilocus Sequence Typing<br/>Plasmids<br/>Polymerase Chain Reaction<br/>Prevalence<br/>Quinolones<br/>Serogroup<br/>Virulence Factors--genetics<br/>Young Adult<br/>beta-Lactamases--genetics